Design
Review
Key result
Hypertension, dyslipidemia, and glucose intolerance act synergistically to increase coronary artery disease risk through complex pathophysiological mechanisms involving the vessel wall.
Authors
Loading...
May warrant integrated metabolic risk management in CAD; extends mechanistic insights but remains hypothesis-generating for therapies.
Hypertension, dyslipidemia, and glucose intolerance act synergistically to increase coronary artery disease risk through complex interacting pathophysiological mechanisms.
Victor J. Dzau (1990) conducted a review in Atherosclerosis and Hypertension. Hypertension, dyslipidemia, and glucose intolerance act synergistically to increase coronary artery disease risk through complex pathophysiological mechanisms involving the vessel wall.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: